Primary congenital hypothyroidism

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:226295
Who is this for?
Show terms as
17Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Primary congenital hypothyroidism (CH) is a condition present at birth in which the thyroid gland fails to produce adequate amounts of thyroid hormones, most commonly thyroxine (T4) and triiodothyronine (T3). It is one of the most common preventable causes of intellectual disability worldwide. The condition may result from thyroid dysgenesis (absent, ectopic, or hypoplastic thyroid gland), which accounts for approximately 80-85% of cases, or from thyroid dyshormonogenesis (defects in thyroid hormone synthesis), which accounts for most of the remaining cases. In rare instances, it can also be caused by defects in TSH receptor signaling. Thyroid hormones are essential for normal growth and neurodevelopment, particularly during the first years of life. Without early detection and treatment, affected infants may develop severe and irreversible intellectual disability, growth failure, and neurological impairment. In the neonatal period, symptoms can be subtle but may include prolonged jaundice, feeding difficulties, constipation, a large fontanelle, hypotonia (decreased muscle tone), macroglossia (enlarged tongue), umbilical hernia, dry skin, hoarse cry, and lethargy. Many affected newborns appear clinically normal at birth, which underscores the critical importance of newborn screening programs. Newborn screening for congenital hypothyroidism, now implemented in most developed countries, allows early diagnosis typically within the first two weeks of life. Treatment consists of lifelong thyroid hormone replacement therapy with levothyroxine (synthetic T4), which should be initiated as soon as possible after diagnosis — ideally within the first two weeks of life. With prompt and adequate treatment, children with primary congenital hypothyroidism can achieve normal or near-normal cognitive development and growth. Regular monitoring of thyroid function tests is essential to ensure appropriate dosing throughout childhood and into adulthood.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Primary congenital hypothyroidism.

View clinical trials →

No actively recruiting trials found for Primary congenital hypothyroidism at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Primary congenital hypothyroidism community →

Specialists

17 foundView all specialists →
JT
Jing-Li Tian
Specialist
2 Primary congenital hypothyroidism publications
YS
Yuan-Zong Song
Specialist
2 Primary congenital hypothyroidism publications
XH
Xiao-Ling Huang
Specialist
2 Primary congenital hypothyroidism publications
LS
Laurent Servais
Specialist
PI on 1 active trial28 Primary congenital hypothyroidism publications
AM
Anita Morandi
Specialist
1 Primary congenital hypothyroidism publication
CM
Claudio Maffeis
Specialist
1 Primary congenital hypothyroidism publication
VL
Valentina Lupieri
Specialist
1 Primary congenital hypothyroidism publication
EK
Eirini Kostopoulou
Specialist
1 Primary congenital hypothyroidism publication
KM
Konstantinos Miliordos
Specialist
1 Primary congenital hypothyroidism publication
BS
Bessie Spiliotis
Specialist
1 Primary congenital hypothyroidism publication
GS
Gabor Szinnai
Specialist
1 Primary congenital hypothyroidism publication
NS
Nadia Schoenmakers
Specialist
1 Primary congenital hypothyroidism publication
FG
Francisca Grob
Specialist
1 Primary congenital hypothyroidism publication
SL
Samantha Lain
Specialist
1 Primary congenital hypothyroidism publication
AC
Aurore Carré
Specialist
1 Primary congenital hypothyroidism publication
AS
Athanasia Stoupa
Specialist
1 Primary congenital hypothyroidism publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Primary congenital hypothyroidism.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Primary congenital hypothyroidismForum →

No community posts yet. Be the first to share your experience with Primary congenital hypothyroidism.

Start the conversation →

Latest news about Primary congenital hypothyroidism

No recent news articles for Primary congenital hypothyroidism.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Primary congenital hypothyroidism

What is Primary congenital hypothyroidism?

Primary congenital hypothyroidism (CH) is a condition present at birth in which the thyroid gland fails to produce adequate amounts of thyroid hormones, most commonly thyroxine (T4) and triiodothyronine (T3). It is one of the most common preventable causes of intellectual disability worldwide. The condition may result from thyroid dysgenesis (absent, ectopic, or hypoplastic thyroid gland), which accounts for approximately 80-85% of cases, or from thyroid dyshormonogenesis (defects in thyroid hormone synthesis), which accounts for most of the remaining cases. In rare instances, it can also be c

At what age does Primary congenital hypothyroidism typically begin?

Typical onset of Primary congenital hypothyroidism is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Primary congenital hypothyroidism?

17 specialists and care centers treating Primary congenital hypothyroidism are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.